{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T19:51:07Z","timestamp":1778788267598,"version":"3.51.4"},"reference-count":47,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Italian Association for Cancer Research","doi-asserted-by":"crossref","award":["2008\u2009N. 6421"],"award-info":[{"award-number":["2008\u2009N. 6421"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.prp.2018.04.018","type":"journal-article","created":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T05:05:12Z","timestamp":1525151112000},"page":"835-839","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["MiR-21 up-regulation in ampullary adenocarcinoma and its pre-invasive lesions"],"prefix":"10.1016","volume":"214","author":[{"given":"Deborah","family":"Saraggi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Galuppini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe N.","family":"Fanelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2564-2988","authenticated-orcid":false,"given":"Andrea","family":"Remo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuele D.L.","family":"Urso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo Q.","family":"Bao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah","family":"Bacchin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenza","family":"Guzzardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"Luchini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4835-1259","authenticated-orcid":false,"given":"Chiara","family":"Braconi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2944-1374","authenticated-orcid":false,"given":"Fabio","family":"Farinati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Rugge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Fassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2018.04.018_bib0005","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1159\/000083470","article-title":"Delayed diagnosis and lower resection rate of adenocarcinoma of the distal duodenum","volume":"21","author":"Stell","year":"2004","journal-title":"Dig. Surg."},{"key":"10.1016\/j.prp.2018.04.018_bib0010","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1200\/JCO.2012.46.8868","article-title":"Histomolecular phenotypes and outcome in adenocarcinoma of the ampulla of vater","volume":"31","author":"Chang","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.prp.2018.04.018_bib0015","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1097\/PAS.0b013e31826399d8","article-title":"Ampullary region carcinomas: definition and site specific classification with delineation of four clinicopathologically and prognostically distinct subsets in an analysis of 249 cases","volume":"36","author":"Adsay","year":"2012","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2018.04.018_bib0020","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s00428-007-0444-1","article-title":"Prognostic factors for ampullary adenocarcinomas: tumor stage, tumor histology, tumor location, immunohistochemistry and microsatellite instability","volume":"451","author":"Sessa","year":"2007","journal-title":"Virchows Arch."},{"key":"10.1016\/j.prp.2018.04.018_bib0025","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1097\/PAS.0000000000000230","article-title":"The utility of immunohistochemistry in subtyping adenocarcinoma of the ampulla of vater","volume":"38","author":"Ang","year":"2014","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2018.04.018_bib0030","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1038\/modpathol.2016.124","article-title":"Ampullary carcinoma is often of mixed or hybrid histologic type: an analysis of reproducibility and clinical relevance of classification as pancreatobiliary versus intestinal in 232 cases","volume":"29","author":"Reid","year":"2016","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.prp.2018.04.018_bib0035","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/bjc.2015.172","article-title":"Validation of histomolecular classification utilizing histological subtype, MUC1, and CDX2 for prognostication of resected ampullary adenocarcinoma","volume":"113","author":"Schueneman","year":"2015","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.prp.2018.04.018_bib0040","series-title":"WHO Classification of Tumours of the Digestive System","author":"Bosman","year":"2010"},{"key":"10.1016\/j.prp.2018.04.018_bib0045","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/SLA.0000000000001999","article-title":"Ampulla of vater carcinoma: sequencing analysis identifies TP53 status as a novel independent prognostic factor and potentially actionable ERBB, PI3K, and WNT pathways gene mutations","volume":"267","author":"Mafficini","year":"2018","journal-title":"Ann. Surg."},{"key":"10.1016\/j.prp.2018.04.018_bib0050","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/his.13254","article-title":"PD-L1 overexpression in ampulla of Vater carcinoma and its pre-invasive lesions","volume":"71","author":"Saraggi","year":"2017","journal-title":"Histopathology"},{"key":"10.1016\/j.prp.2018.04.018_bib0055","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/nrg1379","article-title":"MicroRNAs: small RNAs with a big role in gene regulation","volume":"5","author":"He","year":"2004","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.prp.2018.04.018_bib0060","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/path.2586","article-title":"MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets","volume":"219","author":"Baffa","year":"2009","journal-title":"J. Pathol."},{"key":"10.1016\/j.prp.2018.04.018_bib0065","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1001\/jama.297.17.1901","article-title":"MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis","volume":"297","author":"Bloomston","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.prp.2018.04.018_bib0070","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s40364-017-0087-6","article-title":"Tissue MicroRNA profiles as diagnostic and prognostic biomarkers in patients with resectable pancreatic ductal adenocarcinoma and periampullary cancers","volume":"5","author":"Calatayud","year":"2017","journal-title":"Biomark. Res."},{"key":"10.1016\/j.prp.2018.04.018_bib0075","doi-asserted-by":"crossref","first-page":"e10630","DOI":"10.1371\/journal.pone.0010630","article-title":"Identification of microRNA-21 as a biomarker for chemoresistance and clinical outcome following adjuvant therapy in resectable pancreatic cancer","volume":"5","author":"Hwang","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.prp.2018.04.018_bib0080","doi-asserted-by":"crossref","first-page":"4528","DOI":"10.1158\/0008-5472.CAN-09-4467","article-title":"MicroRNA-21 in pancreatic cancer: correlation with clinical outcome and pharmacologic aspects underlying its role in the modulation of gemcitabine activity","volume":"70","author":"Giovannetti","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.prp.2018.04.018_bib0085","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1053\/j.gastro.2013.10.010","article-title":"MicroRNAs cooperatively inhibit a network of tumor suppressor genes to promote pancreatic tumor growth and progression","volume":"146","author":"Frampton","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.prp.2018.04.018_bib0090","doi-asserted-by":"crossref","first-page":"678401","DOI":"10.1155\/2014\/678401","article-title":"Molecular mechanisms underlying the role of microRNAs in the chemoresistance of pancreatic cancer","volume":"2014","author":"Garajova","year":"2014","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.prp.2018.04.018_bib0095","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/modpathol.2011.142","article-title":"Association of microRNA-21 expression with its targets, PDCD4 and TIMP3, in pancreatic ductal adenocarcinoma","volume":"25","author":"Nagao","year":"2012","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.prp.2018.04.018_bib0100","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1136\/jcp.2010.078253","article-title":"Programmed cell death 4 (PDCD4) expression during multistep Barrett\u2019s carcinogenesis","volume":"63","author":"Fassan","year":"2010","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.prp.2018.04.018_bib0105","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00428-011-1046-5","article-title":"PDCD4 nuclear loss inversely correlates with miR-21 levels in colon carcinogenesis","volume":"458","author":"Fassan","year":"2011","journal-title":"Virchows Arch."},{"key":"10.1016\/j.prp.2018.04.018_bib0110","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2174\/1389450116666141210091454","article-title":"MicroRNAs as tools and effectors for patient treatment in gastrointestinal carcinogenesis","volume":"16","author":"D'Angelo","year":"2015","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.prp.2018.04.018_bib0115","doi-asserted-by":"crossref","first-page":"6611","DOI":"10.18632\/oncotarget.2245","article-title":"Circulating miR-182 is a biomarker of colorectal adenocarcinoma progression","volume":"5","author":"Perilli","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.prp.2018.04.018_bib0120","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1002\/ijc.25823","article-title":"MicroRNA expression profiling in human Barrett\u2019s carcinogenesis","volume":"129","author":"Fassan","year":"2011","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.prp.2018.04.018_bib0125","doi-asserted-by":"crossref","first-page":"5231","DOI":"10.3748\/wjg.v17.i48.5231","article-title":"miRNAs in precancerous lesions of the gastrointestinal tract","volume":"17","author":"Fassan","year":"2011","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.prp.2018.04.018_bib0130","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00428-012-1345-5","article-title":"PDCD4\/miR-21 dysregulation in inflammatory bowel disease-associated carcinogenesis","volume":"462","author":"Ludwig","year":"2013","journal-title":"Virchows Arch."},{"key":"10.1016\/j.prp.2018.04.018_bib0135","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1442-2050.2011.01236.x","article-title":"Programmed cell death 4 nuclear loss and miR-21 or activated Akt overexpression in esophageal squamous cell carcinogenesis","volume":"25","author":"Fassan","year":"2012","journal-title":"Dis. Esophagus"},{"key":"10.1016\/j.prp.2018.04.018_bib0140","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1038\/modpathol.2012.122","article-title":"MicroRNA expression profiles associated with pancreatic adenocarcinoma and ampullary adenocarcinoma","volume":"25","author":"Schultz","year":"2012","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.prp.2018.04.018_bib0145","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.humpath.2015.02.007","article-title":"HER2 status in gastroesophageal cancer: a tissue microarray study of 1040 cases","volume":"46","author":"Cappellesso","year":"2015","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.prp.2018.04.018_bib0150","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s10120-013-0315-1","article-title":"High-throughput mutation profiling identifies novel molecular dysregulation in high-grade intraepithelial neoplasia and early gastric cancers","volume":"17","author":"Fassan","year":"2014","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.prp.2018.04.018_bib0155","doi-asserted-by":"crossref","first-page":"5879","DOI":"10.3748\/wjg.v22.i26.5879","article-title":"HER2 heterogeneity in gastric\/gastroesophageal cancers: from benchside to practice","volume":"22","author":"Grillo","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.prp.2018.04.018_bib0160","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ccell.2015.12.012","article-title":"Genomic sequencing identifies ELF3 as a driver of ampullary carcinoma","volume":"29","author":"Yachida","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.prp.2018.04.018_bib0165","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.18632\/oncotarget.1943","article-title":"Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups","volume":"5","author":"Simbolo","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.prp.2018.04.018_bib0170","first-page":"3156","article-title":"K-ras mutation, p53 overexpression, and microsatellite instability in biliary tract cancers: a population-based study in China","volume":"8","author":"Rashid","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.prp.2018.04.018_bib0175","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1369\/0022155414537277","article-title":"Pretreatment MicroRNA level and outcome in sorafenib-treated hepatocellular carcinoma","volume":"62","author":"Gyongyosi","year":"2014","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.prp.2018.04.018_bib0180","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/cncy.21646","article-title":"Young investigator challenge: microRNA-21\/MicroRNA-126 profiling as a novel tool for the diagnosis of malignant mesothelioma in pleural effusion cytology","volume":"124","author":"Cappellesso","year":"2016","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.prp.2018.04.018_bib0185","doi-asserted-by":"crossref","first-page":"12672","DOI":"10.18632\/oncotarget.7208","article-title":"miR-21 expression and clinical outcome in locally advanced pancreatic cancer: exploratory analysis of the pancreatic cancer Erbitux, radiotherapy and UFT (PERU) trial","volume":"7","author":"Khan","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.prp.2018.04.018_bib0190","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1089\/thy.2012.0045","article-title":"MicroRNA profiles in familial and sporadic medullary thyroid carcinoma: preliminary relationships with RET status and outcome","volume":"22","author":"Mian","year":"2012","journal-title":"Thyroid"},{"key":"10.1016\/j.prp.2018.04.018_bib0195","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.humpath.2014.09.006","article-title":"The PDCD4\/miR-21 pathway in medullary thyroid carcinoma","volume":"46","author":"Pennelli","year":"2015","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.prp.2018.04.018_bib0200","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00428-012-1352-6","article-title":"PDCD4 expression in thyroid neoplasia","volume":"462","author":"Pennelli","year":"2013","journal-title":"Virchows Arch."},{"key":"10.1016\/j.prp.2018.04.018_bib0205","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.celrep.2015.12.005","article-title":"Ampullary cancers harbor ELF3 tumor suppressor gene mutations and exhibit frequent WNT dysregulation","volume":"14","author":"Gingras","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.prp.2018.04.018_bib0210","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/modpathol.2015.57","article-title":"Sequencing of 279 cancer genes in ampullary carcinoma reveals trends relating to histologic subtypes and frequent amplification and overexpression of ERBB2 (HER2)","volume":"28","author":"Hechtman","year":"2015","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.prp.2018.04.018_bib0215","doi-asserted-by":"crossref","first-page":"8164","DOI":"10.1158\/0008-5472.CAN-08-1305","article-title":"MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells","volume":"68","author":"Papagiannakopoulos","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.prp.2018.04.018_bib0220","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s002689910011","article-title":"Clinicopathologic correlation of p53 protein overexpression in adenoma and carcinoma of the ampulla of Vater","volume":"24","author":"Park","year":"2000","journal-title":"World J. Surg."},{"key":"10.1016\/j.prp.2018.04.018_bib0225","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3892\/mmr.2016.5971","article-title":"MicroRNA21 promotes migration and invasion of glioma cells via activation of Sox2 and betacatenin signaling","volume":"15","author":"Luo","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.prp.2018.04.018_bib0230","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.apjtm.2015.05.003","article-title":"Mechanism of miR-21 via Wnt\/beta-catenin signaling pathway in human A549 lung cancer cells and Lewis lung carcinoma in mice","volume":"8","author":"Wu","year":"2015","journal-title":"Asian Pac. J. Trop. Med."},{"key":"10.1016\/j.prp.2018.04.018_bib0235","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/j.1365-2559.2012.04272.x","article-title":"Early HER2 dysregulation in gastric and oesophageal carcinogenesis","volume":"61","author":"Fassan","year":"2012","journal-title":"Histopathology"}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033818303182?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033818303182?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T17:26:27Z","timestamp":1717262787000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033818303182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S0344033818303182"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2018.04.018","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MiR-21 up-regulation in ampullary adenocarcinoma and its pre-invasive lesions","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2018.04.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}]}}